| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |